Rosalind Advisors, Inc. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 4:03 pm Purchase |
2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 715,231 9.900% |
250,554 (+53.92%) |
Filing |
| 2024-05-29 3:47 pm Unchanged |
2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 464,677 9.900% |
0 (Unchanged) |
Filing |
| 2024-05-29 3:43 pm Purchase |
2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 464,677 9.900% |
464,677 (New Position) |
Filing |